~~<i id='8E8E29E710'><strike id='8E8E29E710'><tt id='8E8E29E710'><pre id='8E8E29E710'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：Wikipedia 2025-09-06 01:58:36 - browse：29788

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Group opposing PBM reform sets lobbying record

Wikipedia

leisure time

entertainment

hotspot

focus

AlexHogan/STATJohnGoodsonpracticedmedicineforalmost50yearsatMassachusettsGeneralHospitalinBoston.Asa

WSS

Biden tests positive for Covid

California wildfire smoke linked to 52,000 early deaths, study says

Coercive sterilizations revealed by STAT prompt outrage

Readers discuss the intersection of pregnancy and addiction

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

STAT Virtual Event: The State of Biosimilars: What to Watch

hotspot

fashion

Wikipedia

How to save PrEP access — and even expand it

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Biden tests positive for Covid

ChatGPT in medicine: STAT answers readers' burning questions

Health care court cases: Humana, Sutter, Novant

Activists slam private health insurers over coverage restrictions

STAT Virtual Event: The State of Biosimilars: What to Watch

Virginia high school admissions case could be legal follow

ALS patient reclaims some autonomy thanks to wearable 'robot'

leisure time

AI can’t replace a physician’s gut feeling

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Listen: Wegovy in the brain & pivotal Alzheimer's data

Moderna says combo Covid

Report captures long Covid’s disabling effects and policy challenges

As digital health tech proliferates, a new institute aims to cut through hype

entertainment

hotspot

hotspot

focus